Loading
NASDAQHealthcareMedical - Devices
Latest quote
$10.33
−$0.26 · -2.46%
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
Latest quote
$10.33
−$0.26 · -2.46%
After-hours
$10.33
$0.00 · 0.00%
Oct 8, 7:30 PM ET
Regular session · ET · Market data may be delayed.
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
Day range
Current $10.33
52-week range
Current $10.33
Regular session · ET · Market data may be delayed.
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
Day range
Current $10.33
52-week range
Current $10.33
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 1.02B USD | 948.87M USD | 935.93M USD |
| Cost of goods sold | 905.9M USD | 852.61M USD | 836.96M USD |
| Gross profit | 117.19M USD | 96.26M USD | 98.97M USD |
| Selling, general, and administrative | 90.45M USD | 70.36M USD | 55.17M USD |
| Operating expenses | 90.45M USD | 41.02M USD | 76.52M USD |
| Interest expense | 118.54M USD | 136.03M USD | 141.69M USD |
| Depreciation and amortization | 55.39M USD | 57.16M USD | 72.14M USD |
| Operating income | 26.73M USD | 55.24M USD | 22.45M USD |
| Net income | −47.1M USD | −94.1M USD | −122.23M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$16.40
58.76% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI8.88M0.00%2.3T USD0.03%$379.56-0.39%
iShares Russell 2000 ETFIWM5.26M0.01%78.56B USD0.19%$277.57-0.05%
Vanguard Extended Market ETFVXF3.34M0.00%95.4B USD0.05%$233.13-0.15%
Schwab U.S. Small-Cap ETFSCHA1.38M0.01%21.7B USD0.03%$32.66+0.15%
Vanguard Russell 2000 ETFVTWO1.27M0.01%18B USD0.06%$112.1-0.10%
Vanguard Health Care ETFVHT584.75K0.00%22B USD0.09%$313.85-0.46%
Franklin Small Cap Enhanced ETFFSML404.49K0.27%150.08M USD0.45%$28.9132+0.23%
Fidelity Nasdaq Composite Index ETFONEQ326.44K—10.94B USD0.21%$107.13-1.22%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOVanguard Health Care ETFVHTFranklin Small Cap Enhanced ETFFSMLFidelity Nasdaq Composite Index ETFONEQAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
